Dexmedetomidine Use and Intensive Care Unit Admissions for Patients With Medetomidine Withdrawal

This cohort study examines trends in dexmedetomidine administration and intensive care unit (ICU) admissions between 2020 and 2025 among hospitalized patients with opioid use disorder in Philadelphia, Pennsylvania.

Corresponding Author: Tyler G. Boyce, MD, Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104 (tyler.boyce@pennmedicine.upenn.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.